While inotropic interventions for HF might improve short-term hemodynamics, β-AR agonists have long-term effects that have failed to improve outcomes and can even worsen as excessive release of catecholamines induces apoptosis, increased heart rate, and arrhythmias [328,329]. The gene discussed is ADRB2; the disease is hydrops fetalis.